This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_LIPORALPHARYNX_EXALLC for full statistics.
Carcinoma in situ of lip, oral cavity and pharynx
CD2_INSITU_LIPORALPHARYNX
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
87 |
4. Check minimum number of eventsNone |
87 |
5. Include endpointsNone |
87 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00
- Name in latin
- Carcinoma in situ labii (oris)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of lip, oral cavity and pharynx
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of lip, oral cavity and pharynx
- Carcinoma in situ of oral cavity, oesophagus and stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 29 | 58 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 67.18 | 69.00 | 66.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 73
- Matched controls
- 729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
49.2
22.1
26
8
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
18.5
17
*
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
14.0
13
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
25.9
13.3
18
9
D00.09
ICD-10 Finland
Unspecified cancer in situ in oral cavity and throat
+∞
12.9
12
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
155.7
12.9
13
*
SBA00
NOMESCO Finland
Microbiological examinations
155.7
12.9
13
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
77.8
12.0
13
*
EKA10
NOMESCO Finland
Biopsy of cheek
23.1
10.8
15
8
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
10.7
10
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
10.7
10
*
TEA00
NOMESCO Finland
Biopsy of lip
63.8
9.9
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.4
9.9
17
16
D00.04
ICD-10 Finland
In situ cancer of the floor of the mouth
+∞
9.6
9
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
57.1
8.9
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.7
8.8
39
143
K13.78
ICD-10 Finland
Other change in the oral mucosa
23.5
8.8
12
6
ECA20
NOMESCO Finland
Biopsy of gingiva
31.8
8.8
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
4.5
8.5
40
154
EAA10
NOMESCO Finland
Excision of lesion of lip
50.6
7.9
9
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
21.2
7.9
11
6
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
7.4
7
*
D00.01
ICD-10 Finland
In situ cancer of the mucous membrane of the cheek
+∞
7.4
7
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
19.0
7.0
10
6
A07AA02
ATC
nystatin; oral
7.6
7.0
16
26
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
14.1
6.8
11
9
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
76.2
6.5
7
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
76.2
6.5
7
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
29.5
6.4
8
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
6.3
6
*
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
6.3
6
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
6.3
6
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.0
6.1
20
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
62
5.55
11.01
2.8
2.4
0.2
0.2
g/l
0.13
26
53
10
7
15.90
6.57
3.4
1.3
—
—
—
0
0
49
291
2.57
4.45
5.6
4.2
—
—
—
0
0
30
146
2.61
4.05
3.3
2.6
—
—
—
0
0
21
92
2.69
3.44
6.9
8.2
0.5
1.6
mmol/l
0.71
16
71
15
55
3.09
3.35
2.1
1.3
—
—
—
0
0
24
114
2.53
3.34
2.4
2.5
0.3
0.8
e6/l
1.60
18
67
23
109
2.51
3.21
1.6
1.8
28.5
29.4
s
0.52
23
103
44
277
2.19
3.19
2.2
2.0
86.0
92.8
pmol/l
0.48
24
139
12
40
3.32
3.11
2.3
1.6
—
—
—
0
0
40
248
2.13
2.96
2.2
2.4
77.4
75.2
nmol/l
0.20
35
213
24
122
2.34
2.86
2.8
1.9
—
—
—
0
0
17
76
2.54
2.65
3.2
2.8
19.5
8.8
umol/l
0.37
17
63
18
85
2.41
2.50
2.3
1.7
—
—
—
0
0
6
13
4.87
2.31
1.3
1.5
—
—
—
0
0
32
200
1.95
2.20
3.6
3.1
0.4
0.5
e6/l
0.13
26
149
6
17
3.71
1.87
1.8
1.1
—
—
—
0
0
17
89
2.13
1.86
2.1
1.8
—
—
—
0
0
50
377
1.77
1.80
13.3
10.0
4.4
4.4
e9/l
0.01
45
323
13
63
2.25
1.70
5.4
4.2
1.7
2.9
mmol/l
0.44
13
50
6
20
3.14
1.61
1.8
1.6
—
—
—
0
0
8
33
2.56
1.58
4.1
2.9
2.0
1.2
%
—
8
33
37
264
1.70
1.57
4.0
3.2
—
—
—
0
0
6
21
2.99
1.53
1.8
1.6
—
—
—
0
0
75
655
2.05
1.50
31.5
16.3
40.8
25.0
mg/l
1.95
62
532
6
22
2.85
1.46
4.5
2.4
—
—
—
0
0
5
16
3.25
1.46
1.6
1.2
—
—
—
0
0
12
61
2.12
1.40
1.4
1.6
—
—
—
0
0
6
23
2.72
1.39
3.5
2.1
—
—
—
0
0
18
108
1.84
1.35
2.8
2.6
1.5
2.3
e6/l
0.36
12
62
15
85
1.92
1.33
4.9
4.0
218.8
263.1
u/l
1.17
15
77
6
24
2.61
1.33
4.8
3.3
21.7
36.5
mg/l
—
6
19
21
134
1.75
1.30
1.4
1.7
1205.2
1361.0
nmol/l
0.31
16
100
16
94
1.86
1.28
10.9
10.2
—
—
—
0
0
8
36
2.34
1.28
1.3
2.1
—
—
—
0
0
5
19
2.73
1.23
1.0
1.5
—
—
—
0
0
17
106
1.75
1.13
2.6
2.3
15.8
21.9
%
1.26
12
94
11
62
1.89
0.99
2.1
2.6
334.0
338.3
nmol/l
0.02
11
53
43
351
1.45
0.90
2.9
2.7
—
—
—
0
0
6
30
2.07
0.89
1.0
1.5
—
—
—
0
0
8
46
1.81
0.85
8.0
7.1
23.6
25.4
mmol/l
—
8
46
6
33
1.88
0.80
1.2
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
23
2.24
0.77
2.8
1.7
0.2
0.3
u/ml
—
5
8
5
30
1.71
0.62
12.2
3.0
—
—
—
0
0
5
86
0.56
0.60
4.0
3.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
1.7
—
0
11
35
304
1.25
0.41
4.7
4.5
21.0
49.1
ng/l
1.80
27
242
32
276
1.25
0.40
3.8
4.3
13.3
22.0
%
3.83
12
139
45
407
1.22
0.35
5.0
3.0
79.9
57.6
u/l
0.78
45
379
23
267
0.81
0.32
4.6
4.2
—
—
—
0
0
8
65
1.25
0.28
1.3
1.5
—
—
—
0
0
23
201
1.20
0.24
1.7
2.8
0.5
0.8
ug/l
1.26
14
135
5
39
1.30
0.23
2.0
3.2
0.3
0.1
e6/l
—
5
39
5
42
1.20
0.22
1.4
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
3.0
—
0
5
72
696
1.20
0.20
37.6
19.3
84.8
83.8
umol/l
0.11
72
696
9
82
1.11
0.15
3.3
4.5
5.5
137.7
ug/l
—
9
71
62
611
1.05
0.03
29.0
16.1
72.2
76.2
ml/min/173m2
0.74
56
492
70
698
1.01
0.00
17.8
10.4
28.8
25.2
u/l
0.69
70
670
0
9
0.00
0.00
0.0
1.2
—
349.3
—
0
9
0
9
0.00
0.00
0.0
1.2
—
103.7
—
0
9
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
96.2
—
0
6
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
17.7
—
0
6
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_LIPORALPHARYNX – Carcinoma in situ of lip, oral cavity and pharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).